Lsv Asset Management Alkermes Plc. Transaction History
Lsv Asset Management
- $41.7 Billion
- Q1 2025
A detailed history of Lsv Asset Management transactions in Alkermes Plc. stock. As of the latest transaction made, Lsv Asset Management holds 182,965 shares of ALKS stock, worth $4.78 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
182,965
Previous 372,400
50.87%
Holding current value
$4.78 Million
Previous $10.7 Million
43.59%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ALKS
# of Institutions
405Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$761 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$476 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$308 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$210 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$180 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.29B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...